Novartis Settles US Exforge Case For $245m

Originator Had Been Accused Of Unlawful Deal With Par To Maintain Monopoly

 
• By Dave Wallace
  
Exforge pack Novartis
Novartis and Par had been accused of an anti-competitive deal over Exforge • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin